Single Administration of AAV‐m Atp6v1b2 Gene Therapy Rescues Hearing and Vestibular Disorders Caused by Atp6v1b2 ‐Induced Lysosomal Dysfunction in Hair Cells
Advanced Science · 2025
DOI: 10.1002/advs.202408878 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Gege Wei und 15 weiteren Autor:innen. Beteiligte Einrichtung: Senior Department of Otolaryngology Head and Neck Surgery, the 6th Medical Center of Chinese PLA General Hospital, Chinese PLA Medical School, Beijin…. Hauptthemen laut MEDLINE: Genetic Therapy, Lysosomes, Vacuolar Proton-Translocating ATPases, Hair Cells, Auditory. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Beijing Natural Science Foundation, Natural Science Foundation of Beijing Municipality.
Abstract (Originalsprache)
Haploinsufficiency of the ATP6V1B2, a subunit of V‐ATPases, underlies genetic disorders including Dominant deafness‐onychodystrophy (DDOD), deafness, onychodystrophy, osteodystrophy, mental retardation and seizures (DOORS), and Zimmermann‐Laband syndromes, all characterized by congenital hearing loss and onychodystrophy. Effective therapies for ATP6V1B2 ‐associated hearing loss remain elusive. The study generates a hair cell‐specific knockout mouse ( Atp6v1b2 fl/fl ; Atoh1 Cre/+ ) recapitulating the human phenotypes, with pathological features including hair cell loss and abnormal lysosomal morphology and function. To enhance therapeutic precision and minimize toxicity, an optimized adeno‐associated virus‐inner ear vector incorporating promoter enhancer 3 (AAV‐ie‐Eh3) is engineered. A single administration of AAV‐ie‐Eh3‐m Atp6v1b2 into the scala media at postnatal days 0–2, prevented hair cell degeneration, restored lysosome morphology, and robustly rescued auditory and vestibular function for at least 24 weeks. The findings highlight the critical role of Atp6v1b2 in lysosomal function and demonstrate AAV‐ie‐Eh3 as a potent gene delivery tool for inner ear therapy. This study establishes a novel therapeutic paradigm for ATP6V1B2‐ associated hearing loss and vestibular dysfunction, with significant clinical potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Senior Department of Otolaryngology Head and Neck Surgery, the 6th Medical Center of Chinese PLA General Hospital, Chinese PLA Medical School, Beijing, 100853, China.
- State Key Laboratory of Hearing and Balance Science, Beijing, 100853, China.
- National Clinical Research Center for Otolaryngologic Diseases, Beijing, 100853, China.
- Key Laboratory of Hearing Science, Ministry of Education, Beijing, 100853, China.
- Beijing Key Laboratory of Hearing Impairment Prevention and Treatment, Beijing, 100853, China.
- Chinese Institute for Brain Research, Beijing, 102206, China.
ORCID-Profile: Yongyi Yuan
Förderung
- National Natural Science Foundation of China
- Beijing Natural Science Foundation
- Natural Science Foundation of Beijing Municipality
Zitieren
APA
Wei, G., Qiu, S., Gao, X., Zheng, L., Chen, Y., Ma, Y., Feng, H., Yang, J., Dong, G., Nie, H., Zhao, W., Li, X., Wang, G., Xiong, W., Dai, P., & Yuan, Y. (2025). Single Administration of AAV‐m Atp6v1b2 Gene Therapy Rescues Hearing and Vestibular Disorders Caused by Atp6v1b2 ‐Induced Lysosomal Dysfunction in Hair Cells. Advanced Science. https://doi.org/10.1002/advs.202408878
Vancouver
Wei G, Qiu S, Gao X, Zheng L, Chen Y, Ma Y, et al. Single Administration of AAV‐m Atp6v1b2 Gene Therapy Rescues Hearing and Vestibular Disorders Caused by Atp6v1b2 ‐Induced Lysosomal Dysfunction in Hair Cells. Advanced Science. 2025. doi:10.1002/advs.202408878
BibTeX
@article{Wei2025,
author = {Wei, Gege and Qiu, Shiwei and Gao, Xue and Zheng, Lu and Chen, Yijin and Ma, Ying and Feng, Haifeng and Yang, Jinyuan and Dong, Guojie and Nie, Huiyi and Zhao, Weihao and Li, Xiaoge and Wang, Guangqin and Xiong, Wei and Dai, Pu and Yuan, Yongyi},
title = {Single Administration of AAV‐m Atp6v1b2 Gene Therapy Rescues Hearing and Vestibular Disorders Caused by Atp6v1b2 ‐Induced Lysosomal Dysfunction in Hair Cells},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202408878}
}
EUVIMED